PETCT imaging in pancreatic neoplasm: FDG and non-FDG tracers

Pancreatic cancer is considered the 10th most common malignancy globally with a poor prognosis (fourth most common cause of overall cancer deaths). The most common age at diagnosis is 65-74 years. The five-year survival rate is approximately 11.5% as per the latest SEER 17 data (ranging from 44% for localised disease to 3% for distant metastases). Therefore, early diagnosis is vital as it impacts prognosis and survival despite all the treatment options available. Imaging techniques are essential for diagnosis, staging, response evaluation and post-treatment surveillance.

The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.

Stay up to date with
RAD Magazine

Sign up for our newsletter.

We care about your data. Read our privacy policy.